Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Anorexia Nervosa - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. A Comprehensive Overview of Emerging...
-
New York, USA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Anorexia Nervosa Market to Propel by 2032, Predicts DelveInsight | Key Companies - Amgen, COMPASS Pathways, Homeostasis, Benuvia, Artelo...
-
Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological...
-
Positive early signals seen in two investigator-initiated studies presented at the Society of Biological Psychiatry Annual Meeting in New Orleans London, UK – 3 May 2022 COMPASS...
-
CHICAGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Monte Nido & Affiliates, the nation’s leading provider of eating disorder treatment for over 24 years, announces the opening of two residential eating...
-
New York, Nov. 21, 2019 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Changing the Way the World Thinks About Eating Disorders” on Tuesday, December 10,...